Get started
Halozyme Therapeutics, Inc. 0.25% 01-MAR-2027Halozyme Therapeutics, Inc. 0.25% 01-MAR-2027Halozyme Therapeutics, Inc. 0.25% 01-MAR-2027

Halozyme Therapeutics, Inc. 0.25% 01-MAR-2027

No trades
See on Supercharts
Overview
Analysis News

HALO5387960 chart


Full chart

Key terms


Outstanding amount
‪805.00 M‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
0.25% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−0.85%
Maturity date
Mar 1, 2027
Term to maturity
2 years

About Halozyme Therapeutics, Inc. 0.25% 01-MAR-2027


Issuer
Halozyme Therapeutics, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
halozyme.com
Issue date
Mar 24, 2022
FIGI
BBG00ZFDCBK7
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

HALO5387960 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

HALO5387960 news